West Pharmaceutical Services (WST) EPS (Basic) (2009 - 2026)

West Pharmaceutical Services has disclosed EPS (Basic) across 18 years of filings, most recently posting $2.09 for Q2 2026.

• In Q2 2026, EPS (Basic) rose 18.95% year-over-year to $2.09; the TTM figure through Jun 2026 stood at $7.76 (up 18.35% YoY), while the FY2025 annual figure was $6.63, up 1.24% from the prior year.
• EPS (Basic) came in at $2.09 for Q2 2026 at West Pharmaceutical Services, up from $1.88 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $2.46 in Q2 2022 to a low of $1.19 in Q1 2025.
• Average EPS (Basic) over 5 years is $1.8, with a median of $1.8 recorded in 2023.
• Year-over-year, EPS (Basic) slumped 32.43% in 2022 and surged 57.8% in 2026.
• Over 5 years, EPS (Basic) stood at $1.34 in 2022, then soared by 34.15% to $1.8 in 2023, then fell by 2.48% to $1.75 in 2024, then grew by 1.05% to $1.77 in 2025, then rose by 17.81% to $2.09 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $2.09 in Q2 2026, $1.88 in Q1 2026, and $1.77 in Q4 2025.